Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ProNetLink...PNLK...Click here to enter -- Ignore unavailable to you. Want to Upgrade?

To: Warren A. Wilbur, Jr. who wrote (19672)	6/8/1999 1:14:00 AM
From: Stan	Read Replies (1) \| Respond to of 40688

Forget the cholesterol, you want the glicolic (also, glycolic) acid because, according to Jussara Perssonelle,MD. and Rogerio de Oliveira Ruiz,MD.: Considering the chemical and structural characteristics of the glycolic acid, the superficial application at 0,01% of the injectable intradermic liquid provokes, by being hydrophilic, fast diffusion of the acqueus inter cellular phase and acts as a kerato regulator inhibiting the cohesion of the still on growing corneocytes in layers of the stratum corneum thus promoting a better flexiblity , hidration and turgidity of the cutaneous tegument. The intradermic liquid therapeutics has been applied in cases of acne, ichthyosis, thin creases, acneic keratosis, hyperpigmentation and hypertrophyc scars. So, there! <G> Stan